載入中
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.
前收盤價
US$432.85
+US$5.18 · +1.21%
盤中時間採用ET。市場資料可能有所延遲。
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.
日內區間
目前US$432.85
52週區間
目前US$432.85
盤中時間採用ET。市場資料可能有所延遲。
Bruker Corporation, together with its subsidiaries, develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions. It operates through four segments: Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Bruker Energy & Supercon Technologies. The company offers magnetic resonance spectroscop, preclinical imaging, biopharma and applied, services and lifecycle support, integrated data solution, and automation; life science tools; innovative nuclear magnetic resonance (NMR) and electron paramagnetic resonance (EPR) products; solutions for in-vivo processes and drug discovery; aftermarket solutions; solutions for lab automation and digitalization; mass spectrometry solution and test kits, DNA test strips, and fluorescence-based PCR technologies; genotype and fluorotype molecular diagnostics kits; and research, analytical, and process analysis instruments and solutions. It also provides range of portable analytical and bioanalytical detection systems, and related products; X-ray instruments; analytical tools for electron microscopes, as well as handheld, portable, and mobile X-ray fluorescence spectrometry instruments; atomic force microscopy instrumentation; non-contact nanometer resolution solution topography; and automated X-ray metrology, automated AFM defect-detection, and photomask repair and cleaning equipment. In addition, the company offers advanced optical fluorescence microscopy instruments; services for transcriptional profiling and multiomic analysis; superconducting materials, such as metallic low temperature superconductors; multifilament round and rectangular LTS wires in both monolithic and wire-in-channel formats; designs and manufactures Cuponal; metallic low temperature superconductors; and non-superconducting high technology tools, such as synchrotron and beamline instrumentation. Bruker Corporation was founded in 1960 and is headquartered in Billerica, Massachusetts.
日內區間
目前US$432.85
52週區間
目前US$432.85
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目（USD） | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 34.37億 USD | 33.66億 USD | 29.65億 USD | 25.31億 USD | 24.18億 USD |
| 銷貨成本 | 18.59億 USD | 17.17億 USD | 14.51億 USD | 12.25億 USD | 12.08億 USD |
| 毛利 | 15.78億 USD | 16.5億 USD | 15.13億 USD | 13.06億 USD | 12.1億 USD |
| 研究與開發 | 3.95億 USD | 3.77億 USD | 2.95億 USD | 2.36億 USD | 2.21億 USD |
| 銷售、一般及管理費用 | 9.47億 USD | 8.94億 USD | 7.29億 USD | 6.07億 USD | 5.62億 USD |
| 營業費用 | 13.42億 USD | 13.96億 USD | 10.76億 USD | 8.73億 USD | 7.96億 USD |
| 利息收入 | 1480萬 USD | 930萬 USD | 750萬 USD | 280萬 USD | 90萬 USD |
| 利息支出 | 6030萬 USD | 4790萬 USD | 1640萬 USD | 1610萬 USD | 1430萬 USD |
| 折舊和攤銷 | 2.2億 USD | 1.84億 USD | 1.15億 USD | 8870萬 USD | 8910萬 USD |
| 營業利益 | 2.36億 USD | 2.53億 USD | 4.37億 USD | 4.33億 USD | 4.13億 USD |
| 淨利 | −860萬 USD | 1.13億 USD | 4.27億 USD | 2.97億 USD | 2.77億 USD |
公司資料更新於 2026年10月12日。
近期已公布業績
近期已公布業績
| 行動 | 除息日 | 詳情 | 記錄日期 | 付款日期 |
|---|---|---|---|---|
股息 | 2026年8月14日 | US$3.984Quarterly | 2026年8月15日 | 2026年9月1日 |
股息 | 2026年5月15日 | US$3.988Quarterly | 2026年5月15日 | 2026年6月1日 |
股息 | 2026年2月13日 | US$3.984Quarterly | 2026年2月15日 | 2026年3月2日 |
股息 | 2025年11月14日 | US$3.675Quarterly | 2025年11月15日 | 2025年12月1日 |
除息 2026年8月14日
US$3.984
Quarterly
2026年8月15日登記 · 支付日 2026年9月1日
除息 2026年5月15日
US$3.988
Quarterly
2026年5月15日登記 · 支付日 2026年6月1日
除息 2026年2月13日
US$3.984
Quarterly
2026年2月15日登記 · 支付日 2026年3月2日
除息 2025年11月14日
US$3.675
Quarterly
2025年11月15日登記 · 支付日 2025年12月1日
報告持有此股票曝險的交易所交易基金。
iShares Preferred and Income Securities ETFPFF7117.28萬0.59%121.87億 USD0.45%US$29.38—
VanEck Preferred Securities ex Financials ETFPFXF2975.03萬1.27%23.45億 USD0.40%US$17.66—
State Street SPDR Bloomberg Convertible Securities ETFCWB1370.23萬0.25%——US$100.91—
First Trust SSI Strategic Convertible Securities ETFFCVT49.37萬0.52%——US$48.9615—
iShares Morningstar Multi-Asset Income ETFIYLD11.14萬0.09%1.24億 USD0.50%US$21.60—iShares Preferred and Income Securities ETFPFFVanEck Preferred Securities ex Financials ETFPFXFState Street SPDR Bloomberg Convertible Securities ETFCWBFirst Trust SSI Strategic Convertible Securities ETFFCVTiShares Morningstar Multi-Asset Income ETFIYLDAI 生成內容及延遲市場資料僅供資訊與教育用途，不構成投資建議。
